Abstract
Temporary transvenous cardiac pacing (TTVCP) is crucial and lifesaving procedure for hemodynamically unstable bradyarrhythmia. TTVCP placement under fluoroscopy guidance is considered the “gold-standard”. However, its use is limited by equipment availability. During the COVID-19 pandemic, access to operation-theatre with fluoroscopy service is severely restricted due to delay in confirming patient COVID-19 status (COVID19 PCR 6 h, GeneXpert 2 h). With this limitation, physicians rely on echocardiography guided placement of TTVCP for unstable emergent cases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
